Hecheng Co., Ltd.: the abbreviation of the company's securities is proposed to be changed to "Jianfa Hecheng"

China's First Oral COVID-19 Antiviral Medicine in Dispute

An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.

WIM 2022: Transcript of Fireside Chat of Biotech [1/2]

EqualOcean organized the WIM2022 event in New York City from July 29 to July 30, 2022. The following is the transcript for Fireside Chat of Biotech. Leon Tang, Bing Yuan, Ying Huang, Dahai Guo, and Sally Wang are the five guest speakers in this chat.

WIM 2022: Transcript of Fireside Chat of Biotech [2/2]

EqualOcean organized the WIM2022 event in New York City from July 29 to July 30, 2022. The following is the transcript for Fireside Chat of Biotech. Leon Tang, Bing Yuan, Ying Huang, Dahai Guo, and Sally Wang are the five guest speakers in this chat.

Analysis of Pharmaceutical CRO Industry in China

With the rising demand of global drug R&D and the tightening policies about new drug development in China, contract research organization, also named CRO, captured a particular attention of Chinese pharmaceutical companies and investors. So, how to explain the popularity of the CRO industry in China? Why Chinese CRO companies like to go global? Will the digitalization of CRO services be a new trend in the future? After reading this article, you will know the answers above.

Blood Products Company Taibang Bags USD 300 Mn of Investment

Tabang Biologic Group, founded in 2002, is a blood product and biopharmaceutical company. This financing round will further optimize the Group's capital structure and help it gain a firmer foothold in China's market.